Pyxis Innovations Inc

Controlling interest in Interleukin Genetics (currently 58%) was purchased starting in 2003 as part of Alticor's long term vision to be able to offer personalized health solutions and products, especially nutrition and supplementation, customized or 'personalized' to each person's needs.